Alexander Khoruts, MD

Dr. Khoruts is the Director of the University of Minnesota Microbiota Therapeutics Program. The Program manufactures diff erent therapeutic formulations of fecal microbiota using Good Manufacturing Protocols. These are being tested in multiple clinical trials through a network of academic collaborators. Some of the indications include Crohn’s disease and ulcerative colitis, optimization of cancer therapies, food allergies, antibiotic resistance, hepatic encephalopathy, autism, and others. His main research focus is on development new microbiota-based therapeutics and their dosing regimens using a pharmacologic framework, which includes characterization of pharmacokinetics and pharmacodynamics.